Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Name: Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hla-a*0201 positive cells present, ny-eso-1 positive tumor cells present, recurrent myxoid liposarcoma, recurrent synovial sarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 383555
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.